[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (957)

Search Parameters:
Keywords = paralysis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
14 pages, 928 KiB  
Review
Conservative Treatment of Neonatal Brachial Plexus Palsy: A Narrative Review
by Valentina Boetto, Anna Markova, Federica Malgrati, Isabel Bongiovanni, Anna Bassetto, Chiara Pavese, Antonio Nardone, Giuseppe Massazza, Gabriele Colò and Paolo Titolo
J. Clin. Med. 2024, 13(24), 7826; https://doi.org/10.3390/jcm13247826 (registering DOI) - 21 Dec 2024
Viewed by 259
Abstract
Neonatal brachial plexus palsy (NBPP) is a flaccid paralysis of the upper limbs that occurs in about 0.4 percent of live births. This condition can produce permanent disabilities; to date, there is no consensus on protocols to be applied for the rehabilitation of [...] Read more.
Neonatal brachial plexus palsy (NBPP) is a flaccid paralysis of the upper limbs that occurs in about 0.4 percent of live births. This condition can produce permanent disabilities; to date, there is no consensus on protocols to be applied for the rehabilitation of children with this condition. The aim of this article is to provide a concise overview of conservative treatment beyond traditional physical therapy for the management of the child with NBPP and to offer a number of useful options for creating the most comprehensive and functional rehabilitation treatment possible. We conducted a narrative review after analyzing articles from the past 50 years on PubMed, Cochrane Library, Scopus, and Web of Science with the following search string [(“neonatal brachial plexus palsy” OR “obstetric brachial plexus palsy” OR “birth brachial plexus palsy”) AND (“rehabilitation” OR “physiotherapy” OR “conservative treatment”)]. We identified a potential of 1275 articles, but only 11 were exclusively about conservative approaches. The most represented rehabilitation approaches in the literature were botulinum toxin, constraint-induced movement therapy (CIMT), virtual reality, neuromuscular electrical stimulation, and kinesiotaping. In conclusion, the various rehabilitation approaches for NBPP are promising, but none can be considered the best option when used alone. In light of the current evidence, a multimodal approach is needed. Full article
(This article belongs to the Special Issue Acute Care for Traumatic Injuries and Surgical Outcomes)
Show Figures

Figure 1

Figure 1
<p>A schematic drawing by Dr. Coló of the brachial plexus palsy: (<b>A</b>) relation between plexus and clavicle, (<b>B</b>) plexus injury.</p>
Full article ">
22 pages, 1024 KiB  
Review
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management
by Concepcion F. Estivariz, Elisabeth R. Krow-Lucal and Ondrej Mach
Pathogens 2024, 13(12), 1128; https://doi.org/10.3390/pathogens13121128 - 20 Dec 2024
Viewed by 299
Abstract
Individuals with certain primary immunodeficiency disorders (PID) may be unable to clear poliovirus infection after exposure to oral poliovirus vaccine (OPV). Over time, vaccine-related strains can revert to immunodeficiency-associated vaccine-derived poliovirus (iVDPVs) that can cause paralysis in the patient and potentially spread in [...] Read more.
Individuals with certain primary immunodeficiency disorders (PID) may be unable to clear poliovirus infection after exposure to oral poliovirus vaccine (OPV). Over time, vaccine-related strains can revert to immunodeficiency-associated vaccine-derived poliovirus (iVDPVs) that can cause paralysis in the patient and potentially spread in communities with low immunity. We reviewed the efforts for detection and management of PID patients with iVDPV infections and the epidemiology through an analysis of 184 cases reported to the World Health Organization (WHO) during 1962–2024 and a review of polio program and literature reports. Most iVDPV patients (79%) reported in the WHO Registry were residents in middle-income countries and almost half (48%) in the Eastern Mediterranean Region. Type 2 iVDPV was most frequently isolated (53%), but a sharp decline was observed after the switch to bivalent OPV in 2016, with only six cases reported during 2017–2024 compared to 63 during 2009–2016. Patients with common variable immunodeficiency have longer excretion of iVDPV than with other PID types. Implementation of sensitive sentinel surveillance to detect cases of iVDPV infection in high-risk countries and offer antiviral treatment to patients is challenged by competition with other health priorities and regulatory hurdles to the compassionate use of investigational antiviral drugs. Full article
(This article belongs to the Special Issue Human Poliovirus)
Show Figures

Figure 1

Figure 1
<p>Number of immunodeficiency-associated vaccine-derived poliovirus (iVDPV) isolations reported during 1962–2024 by year of detection and serotype of first positive specimen. The graphic includes 189 isolates in stool specimens from 184 patients with type 1 (n = 42), type 2 (n = 97), and type 3 (n = 50). Five patients with co-infection are counted twice: three patients co-infected with types 1 and 2, one patient with types 2 and 3, and one patient with types 1 and 3.</p>
Full article ">Figure 2
<p>Number of immunodeficiency-associated vaccine-derived poliovirus (iVDPV) cases reported during 1962–2024 by WHO region (N = 184). The x-axis is split in four-year intervals with the total number of cases reported in that year shown as the bar. AFRO—African Region; EMRO—Eastern Mediterranean Region; EURO—European Region; PAHO—Pan-American Health Organization, Region of the Americas; SEARO—South-East Asian Region; WPRO—Western Pacific Region.</p>
Full article ">Figure 3
<p>Geographic location of 184 immunodeficiency-associated vaccine-derived poliovirus (iVDPV) cases reported during 1962–2024 by country and serotype. The total number of iVDPV cases by serotype reported over the time period are represented by pie charts proportional to the number of isolations. Five patients had co-infection. Countries that have reported at least one iVDPV case from 1962 to 2024 to date are highlighted in yellow.</p>
Full article ">
20 pages, 1662 KiB  
Review
Exploring the Role of Axons in ALS from Multiple Perspectives
by Xiaosu Chen, Shuchang Lv, Jinmeng Liu, Yingjun Guan, Chunjie Xu, Xiaonan Ma, Mu Li, Xue Bai, Kexin Liu, Haoyun Zhang, Qiupeng Yan, Fenghua Zhou and Yanchun Chen
Cells 2024, 13(24), 2076; https://doi.org/10.3390/cells13242076 - 17 Dec 2024
Viewed by 561
Abstract
Amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease, is a neurodegenerative disorder characterized by the progressive degeneration of both upper and lower motor neurons. This pathological process results in muscle weakness and can culminate in paralysis. To date, the precise etiology [...] Read more.
Amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease, is a neurodegenerative disorder characterized by the progressive degeneration of both upper and lower motor neurons. This pathological process results in muscle weakness and can culminate in paralysis. To date, the precise etiology of ALS remains unclear. However, a burgeoning body of research indicates that axonal dysfunction is a pivotal element in the pathogenesis of ALS and significantly influences the progression of disease. Dysfunction of axons in ALS can result in impediments to nerve impulse transmission, leading to motor impairment, muscle atrophy, and other associated complications that severely compromise patients’ quality of life and survival prognosis. In this review, we concentrate on several key areas: the ultrastructure of axons, the mechanisms of axonal degeneration in ALS, the impact of impaired axonal transport on disease progression in ALS, and the potential for axonal regeneration within the central nervous system (CNS). Our objective is to achieve a more holistic and profound understanding of the multifaceted role that axons play in ALS, thereby offering a more intricate and refined perspective on targeted axonal therapeutic interventions. Full article
(This article belongs to the Special Issue Axonal Transport: Mechanisms, Disorders, and Therapeutic Approaches)
Show Figures

Figure 1

Figure 1
<p>Axonal damage can be influenced by a variety of risk factors. (<b>a</b>) The length of axon could be a contributing factor to the potential for damage. (<b>b</b>) Abnormal axonal branching is implicated in ALS pathogenesis. (<b>c</b>) Under the influence of gravity, the ATP required by most longitudinal axons to reverse transport metabolic waste back to the cell body is greater than that required by lateral axon transport. This disparity can result in a progressive accumulation of waste at the axonal termini, which, if not promptly recycled, may lead to compromised axonal transport function. The red bidirectional arrow delineates the range; the black arrow highlights the risk factors; the dark green arrows signify direction, and the blue arrows with arcs point to a magnified view of axonal transport impediments resulting from ATP deficiency.</p>
Full article ">Figure 2
<p>The activity of SARM1 is intricately regulated by NAD<sup>+</sup> metabolism. (<b>a</b>) NMN and NAD<sup>+</sup> are known to respectively activate and inhibit the NADase activity of recombinant SARM1. NMN facilitates the degradation of remaining NAD<sup>+</sup> through the activation of SARM1’s NADase activity, resulting in the production of NAM and ADPR (cADPR), which ultimately triggers the degeneration of axons. (<b>b</b>) The deletion of NMNAT2 triggers the activation of SARM1 through the modulation of NAD<sup>+</sup>, NMN, and the NAD<sup>+</sup>/NMN ratio, leading to the degeneration of axons. This degenerative process can be counteracted by the elevated expression of WldS/NMNAT1. The black and pink arrows indicate direction, the purple arrows denote suppression, and the black arrows within parentheses signify trends.</p>
Full article ">Figure 3
<p>The connection between mutations in the genes that cause ALS and axonal transport disorder. (<b>a</b>) The DPRs generated by the <span class="html-italic">C9ORF72</span> gene impair the interaction and motility of motor proteins by competitively occupying the binding sites on the C-terminal tail of microtubules. As a result, the presence of DPRs leads to a higher rate of motor protein dissociation from microtubules. (<b>b</b>) ALS-associated mutant <span class="html-italic">SOD1</span> has been found to inhibit mitochondrial axonal transport by inducing the degradation of Miro1 in a PINK1/Parkin-dependent manner. (<b>c</b>) The augmented viscosity of TDP-43-formed ribonucleoprotein (RNP) particles and the heightened toxic gain-of-function of FUS contribute to transport impediments. The blue and black arrows indicate the direction, the curved blue arrows point to the enlarged structure, the dashed red arrows suggest that increased Miro expression can ameliorate the axonal transport function of the mitochondria, and the arrows in parentheses signify trends.</p>
Full article ">
11 pages, 5867 KiB  
Review
Prevention and Management of Recurrent Laryngeal Nerve Palsy in Minimally Invasive Esophagectomy: Current Status and Future Perspectives
by Yusuke Taniyama, Hiroshi Okamoto, Chiaki Sato, Yohei Ozawa, Hirotaka Ishida, Michiaki Unno and Takashi Kamei
J. Clin. Med. 2024, 13(24), 7611; https://doi.org/10.3390/jcm13247611 - 13 Dec 2024
Viewed by 326
Abstract
Recurrent laryngeal nerve palsy remains a significant complication following minimally invasive esophagectomy for esophageal cancer. Despite advancements in surgical techniques and lymphadenectomy precision, the incidence of recurrent laryngeal nerve palsy has not been improved. Recurrent laryngeal nerve palsy predominantly affects the left side [...] Read more.
Recurrent laryngeal nerve palsy remains a significant complication following minimally invasive esophagectomy for esophageal cancer. Despite advancements in surgical techniques and lymphadenectomy precision, the incidence of recurrent laryngeal nerve palsy has not been improved. Recurrent laryngeal nerve palsy predominantly affects the left side and may lead to unilateral or bilateral vocal cord paralysis, resulting in hoarseness, dysphagia, and an increased risk of aspiration pneumonia. While most cases of recurrent laryngeal nerve palsy are temporary and resolve within 6 to 12 months, some patients may experience permanent nerve dysfunction, severely impacting their quality of life. Prevention strategies, such as nerve integrity monitoring, robotic-assisted minimally invasive esophagectomy, and advanced dissection techniques, aim to minimize nerve injury, though their effectiveness varies. The management of recurrent laryngeal nerve palsy includes voice and swallowing rehabilitation, reinnervation techniques, and, in severe cases, surgical interventions such as thyroplasty and intracordal injection. As recurrent laryngeal nerve palsy can lead to significant postoperative respiratory complications, a multidisciplinary approach involving surgical precision, early detection, and comprehensive rehabilitation is crucial to improving patient outcomes and minimizing long-term morbidity in minimally invasive esophagectomy. This review article aims to inform esophageal surgeons and other clinicians about strategies for the prevention and management of recurrent laryngeal nerve palsy in esophagectomy. Full article
Show Figures

Figure 1

Figure 1
<p>Dissection of right RLN lymph nodes using a robot. (<b>a</b>) Dorsal side of lymph nodes along the right recurrent laryngeal nerve (RLN) are being dissected as the same plane with the dorsal side of the esophagus. This figure demonstrates that the lymphatic chain forming these nodes exhibits a mesenteric-like structure. (<b>b</b>) The lymphatic chain is dissected from the trachea, with the right recurrent laryngeal nerve and subclavian artery serving as the base, resembling a mesenteric structure. (<b>c</b>) As the lymphatic chain is dissected dorsally from the right subclavian artery, the recurrent laryngeal nerve (black arrowhead) naturally becomes visible under the thin membrane. (<b>d</b>) After dividing the esophageal branch of the recurrent laryngeal nerve and dissecting from the lateral wall of the trachea, en bloc resection of the lymphatic chain will be possible (yellow dots).</p>
Full article ">Figure 2
<p>Dissection of left RLN lymph nodes using a robot. (<b>a</b>) A stable surgical field is achieved by retracting the esophagus dorsally with gauze and using the robot to fix the trachea in place. (<b>b</b>) Dissection of the left side of the trachea from the lymphatic chain. The use of the robot allows for precise hemostasis while maneuvering over the trachea. (<b>c</b>) The sympathetic cardiac branch (black arrowhead) is revealed behind the thin membrane, as the lymphatic chain is flipped up. (<b>d</b>) The left RLN (white arrowhead) and its esophageal branch have been preserved, after flipping up the lymphatic chain.</p>
Full article ">Figure 3
<p>Schematic diagram of NIM (Nerve Integrity Monitoring). This diagram illustrates the mechanism of electrical stimulation of the vagus and RLN, which causes vocal cord movement detected via sensors attached to the endotracheal tube. The process is as follows: (<b>1</b>) The RLN is stimulated with a current of 0.5–1.0 mA. (<b>2</b>) The vocal cords move in response to the stimulation. (<b>3</b>) The sensor detects this vocal code movement. (<b>4</b>) The signal is transmitted as electrical impulses through the cord of the NIM endotracheal tube. (<b>5</b>) The stimulation is displayed as an electromyographic signal on the NIM monitor. Yellow arrows: Passage of electrical stimulation and signal to NIM system.</p>
Full article ">Figure 4
<p>Risk of RLN palsy associated with the application of strong forces during robotic esophagectomy. (<b>a</b>) Flexion of the left RLN (black dots) caused by the forceful elevation of the esophagus using the robot. (<b>b</b>) Flexion of the left RLN (black dots) resulting from powerful robotic dissection.</p>
Full article ">
12 pages, 5235 KiB  
Article
Results of the Nerve Transfers and Secondary Procedures to Restore Shoulder and Elbow Function in Traumatic Upper Brachial Plexus Palsy
by Piotr Czarnecki, Michał Górecki and Leszek Romanowski
J. Clin. Med. 2024, 13(23), 7396; https://doi.org/10.3390/jcm13237396 - 4 Dec 2024
Viewed by 545
Abstract
Background: Damage to the upper trunk of the brachial plexus, often caused by high-energy trauma, leads to significant functional impairment of the upper limb. This injury primarily affects the C5 and C6 roots, resulting in paralysis of muscles critical for shoulder and elbow [...] Read more.
Background: Damage to the upper trunk of the brachial plexus, often caused by high-energy trauma, leads to significant functional impairment of the upper limb. This injury primarily affects the C5 and C6 roots, resulting in paralysis of muscles critical for shoulder and elbow function. If spontaneous nerve regeneration does not occur within 3–6 months post-injury, surgical intervention, including nerve transfers, is recommended to restore function. Methods: This study evaluates long-term outcomes of nerve transfer surgeries performed between 2013 and 2023 on 16 adult patients with post-traumatic brachial plexus injuries. The most common cause of injury was motorcycle accidents. Nerve transfers targeted shoulder and elbow function restoration, including transfer of the accessory nerve to the suprascapular nerve, the radial nerve branch to the long or medial head of the triceps brachii to the axillary nerve, or the transfer of motor fascicles of the ulnar and median nerves (double Oberlin) to the brachialis and biceps brachii motor nerves. Results: Postoperative results showed varying degrees of functional recovery. In the shoulder, most patients achieved stabilization and partial restoration of active movement, with average flexion up to 92° and abduction up to 78°. In the elbow, full flexion with M4 strength was achieved in 64% of patients. In both the shoulder and the elbow, double nerve transfers yield better long-term outcomes than single transfers. Secondary procedures, such as tendon transfers, were required in some cases to improve limb strength. Conclusions: The study concludes that nerve transfers offer reliable outcomes in restoring upper limb function, although additional surgeries may be necessary in certain cases. Full article
(This article belongs to the Special Issue State of the Art in Hand Surgery)
Show Figures

Figure 1

Figure 1
<p>A prone position of the patient with marked anatomical landmarks for transferring the accessory nerve to the suprascapular nerve (black arrow) and the branch of the radial nerve for the triceps brachii to the axillary nerve (white arrow).</p>
Full article ">Figure 2
<p>Intraoperative photo on the left side showing the prepared and protected accessory nerve (black asterisk) and the suprascapular nerve (white asterisk) and on the right side after the end-to-end transfer.</p>
Full article ">Figure 3
<p>Intraoperative photo on the left side showing the prepared and protected axillary nerve (white asterisk) and the branch of the radial nerve of the triceps brachii (black asterisk) and on the right side after the end-to-end transfer.</p>
Full article ">Figure 4
<p>Intraoperative photo on the left side showing the dissected and isolated fascicle from the middle of the median nerve (white asterisk), in the middle photo after the Oberlin end-to-end transfer to the motor branch of the biceps brachii muscle (black asterisk), and on the right side after the double Oberlin transfer with the added transfer of the fascicle from the ulnar nerve (white arrow) to the motor branch of the brachialis muscle (black arrow).</p>
Full article ">
21 pages, 10795 KiB  
Article
COSMIC-2 RFI Prediction Model Based on CNN-BiLSTM-Attention for Interference Detection and Location
by Cheng-Long Song, Rui-Min Jin, Chao Han, Dan-Dan Wang, Ya-Ping Guo, Xiang Cui, Xiao-Ni Wang, Pei-Rui Bai and Wei-Min Zhen
Sensors 2024, 24(23), 7745; https://doi.org/10.3390/s24237745 - 4 Dec 2024
Viewed by 506
Abstract
As the application of the Global Navigation Satellite System (GNSS) continues to expand, its stability and safety issues are receiving more and more attention, especially the interference problem. Interference reduces the signal reception quality of ground terminals and may even lead to the [...] Read more.
As the application of the Global Navigation Satellite System (GNSS) continues to expand, its stability and safety issues are receiving more and more attention, especially the interference problem. Interference reduces the signal reception quality of ground terminals and may even lead to the paralysis of GNSS function in severe cases. In recent years, Low Earth Orbit (LEO) satellites have been highly emphasized for their unique advantages in GNSS interference detection, and related commercial and academic activities have increased rapidly. In this context, based on the signal-to-noise ratio (SNR) and radio-frequency interference (RFI) measurements data from COSMIC-2 satellites, this paper explores a method of predicting RFI measurements using SNR correlation variations in different GNSS signal channels for application to the detection and localization of civil terrestrial GNSS interference signals. Research shows that the SNR in different GNSS signal channels shows a correlated change under the influence of RFI. To this end, a CNN-BiLSTM-Attention model combining a convolutional neural network (CNN), bi-directional long and short-term memory network (BiLSTM), and attention mechanism is proposed in this paper, and the model takes the multi-channel SNR time series of the GNSS as the input and outputs the maximum measured value of RFI in the multi-channels. The experimental results show that compared with the traditional band-pass filtering inter-correlation method and other deep learning models, the model in this paper has a root mean square error (RMSE), mean absolute error (MAE), and correlation coefficient (R2) of 1.0185, 1.8567, and 0.9693, respectively, in RFI prediction, which demonstrates a higher RFI detection accuracy and a wide range of rough localization capabilities, showing significant competitiveness. Since the correlation changes in the SNR can be processed to decouple the signal strength, this model is also suitable for future GNSS-RO missions (such as COSMIC-1, CHAMP, GRACE, and Spire) for which no RFI measurements have yet been made. Full article
Show Figures

Figure 1

Figure 1
<p>The different signal transmission paths between the RFI source, the GNSS satellites, and the GNSS RO satellites (not to scale).</p>
Full article ">Figure 2
<p>SNR, S4 scintillation index, elevation angle, and RFI measurements for the POD 01 antenna of C2E1 satellite near 1:35 UTC on 1 January 2023: (<b>a</b>) SNR sequence of CA code L1 band for different channels. (<b>b</b>) S4 scintillation index. (<b>c</b>) Elevation angle of the LEO-GPS link. (<b>d</b>) Maximum value of RFI measurements in multiple channels.</p>
Full article ">Figure 3
<p>Changes in SNR, S4 scintillation index, and RFI measurements of the C2E1 satellite POD 01 antenna when scintillation occurs on 1 January 2023 near 1:10 UTC. (<b>a</b>) SNR sequence of CA code L1 band for different channels. (<b>b</b>) S4 scintillation index. (<b>c</b>) Maximum value of RFI measurements in multiple channels.</p>
Full article ">Figure 4
<p>Results of the interference detection algorithm: (<b>a</b>) The result of band-pass filtering and normalization of the multi-channel SNR sequence in <a href="#sensors-24-07745-f002" class="html-fig">Figure 2</a>a. (<b>b</b>) The calculated cross-correlation sequence after moving window normalization and filtering, as well as interference, can be detected by setting a threshold (set to 0.01 in this example).</p>
Full article ">Figure 5
<p>Spatial distribution of the orbits of GPS and COSMIC-2 satellites during the SNR duration in <a href="#sensors-24-07745-f002" class="html-fig">Figure 2</a>a.</p>
Full article ">Figure 6
<p>Calculation results of the RFI measurement sequence and cross-correlation sequence output by the C2E1 satellite 01 antenna on January 1, 2023 UTC. The two sequences also show a certain degree of correlation over the day: (<b>a</b>) RFI measurement sequence; (<b>b</b>) Calculated normalized cross-correlation sequence after band-pass filtering.</p>
Full article ">Figure 7
<p>Basic structure of a CNN model.</p>
Full article ">Figure 8
<p>LSTM model schematic.</p>
Full article ">Figure 9
<p>Schematic diagram of the BiLSTM model.</p>
Full article ">Figure 10
<p>Basic structure of the CNN-BiLSTM-Attention model used in this paper.</p>
Full article ">Figure 11
<p>Flowchart of the algorithm.</p>
Full article ">Figure 12
<p>Predicted RFI measurements and dRFI for the training set on the COSMIC-2 C2E1 satellite for the CNN-BiLSTM-Attention model. The dashed line in the figure indicates the interference threshold y = ±0.001, with the time resolution downsampled to 3 h: (<b>a</b>) the blue line is the true value of the RFI measurement, and the red line is the prediction result; (<b>b</b>) dRFI.</p>
Full article ">Figure 13
<p>Predicted RFI measurements and dRFI for the training set on the COSMIC-2 C2E1 satellite for the BiLSTM-Attention model. The dashed line in the figure indicates the interference threshold y = ±0.001, with the time resolution downsampled to 3 h: (<b>a</b>) the blue line is the true value of the RFI measurement, and the red line is the prediction result; (<b>b</b>) dRFI.</p>
Full article ">Figure 14
<p>Predicted RFI measurements and dRFI for the training set on the COSMIC-2 C2E1 satellite for the LSTM model. The dashed line in the figure indicates the interference threshold y = ±0.001, with the time resolution downsampled to 3 h: (<b>a</b>) the blue line is the true value of the RFI measurement, and the red line is the prediction result; (<b>b</b>) dRFI.</p>
Full article ">Figure 15
<p>Predicted RFI measurements and dRFI for the test set on the COSMIC-2 C2E1 satellite for the CNN-BiLSTM-Attention model. The dashed line in the figure indicates the interference threshold y = ±0.001, with the time resolution downsampled to 3 h: (<b>a</b>) the blue line is the true value of the RFI measurement, and the red line is the prediction result; (<b>b</b>) dRFI.</p>
Full article ">Figure 16
<p>Predicted RFI measurements and dRFI for the test set on the COSMIC-2 C2E1 satellite for the BiLSTM-Attention model. The dashed line in the figure indicates the interference threshold y = ±0.001, with the time resolution downsampled to 3 h: (<b>a</b>) the blue line is the true value of the RFI measurement, and the red line is the prediction result; (<b>b</b>) dRFI.</p>
Full article ">Figure 17
<p>Predicted RFI measurements and dRFI for the test set on the COSMIC-2 C2E1 satellite for the LSTM model. The dashed line in the figure indicates the interference threshold y = ±0.001, with the time resolution downsampled to 3 h: (<b>a</b>) the blue line is the true value of the RFI measurement, and the red line is the prediction result; (<b>b</b>) dRFI.</p>
Full article ">Figure 18
<p>Global RFI situation map of the six COSMIC-2 satellites’ 01 and 02 antenna superposition cases using the four methods mentioned in this paper and the actual measured values: (<b>a</b>) real measured values, and the three green dotted rectangles inside the marker are the primary sources of prediction error for various algorithms (<b>b</b>) CNN-BiLSTM-Attention, (<b>c</b>) BiLSTM-Attention, (<b>d</b>) LSTM, (<b>e</b>) normalized cross-correlation method with band-pass filtering.</p>
Full article ">Figure 18 Cont.
<p>Global RFI situation map of the six COSMIC-2 satellites’ 01 and 02 antenna superposition cases using the four methods mentioned in this paper and the actual measured values: (<b>a</b>) real measured values, and the three green dotted rectangles inside the marker are the primary sources of prediction error for various algorithms (<b>b</b>) CNN-BiLSTM-Attention, (<b>c</b>) BiLSTM-Attention, (<b>d</b>) LSTM, (<b>e</b>) normalized cross-correlation method with band-pass filtering.</p>
Full article ">
17 pages, 2778 KiB  
Article
High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation
by Luyuan Li, Lily Hashemi, Josiane Eid, Wensi Tao, Leticia Campoverde, Amy Yu, Ammad Ahmad Farooqi, Hassan Al-Ali, Gina D’Amato, Francis Hornicek, Zhenfeng Duan, Ines Lohse and Jonathan Trent
Int. J. Mol. Sci. 2024, 25(23), 13003; https://doi.org/10.3390/ijms252313003 - 3 Dec 2024
Viewed by 729
Abstract
The term chondrosarcoma refers to a rare and heterogeneous group of malignant cartilaginous tumors that are typically resistant to chemotherapy and radiotherapy. Metastatic chondrosarcoma has a poor prognosis, and effective systemic therapies are lacking. Isocitrate dehydrogenase (IDH) mutations represent a potential therapeutic target, [...] Read more.
The term chondrosarcoma refers to a rare and heterogeneous group of malignant cartilaginous tumors that are typically resistant to chemotherapy and radiotherapy. Metastatic chondrosarcoma has a poor prognosis, and effective systemic therapies are lacking. Isocitrate dehydrogenase (IDH) mutations represent a potential therapeutic target, but IDH inhibitors alone have shown limited clinical efficacy to date. Although the role of conventional chemotherapy is still subject to debate, some evidence suggests it may provide therapeutic benefits in advanced cases. In this study, we aimed to identify effective compounds for combination therapy in chondrosarcoma. Using high-throughput screening, we evaluated a panel of anticancer agents in IDH1-mutant chondrosarcoma cell lines and their mutant IDH1 knockout derivatives. The top 20 most potent compounds were identified across all cell lines, irrespective of IDH mutation status. Representative drugs selected for further investigation included docetaxel, methotrexate, panobinostat, idarubicin, camptothecin, and pevonedistat. These drugs inhibited colony formation, induced apoptosis and cell cycle arrest, and exhibited synergistic antitumor activity in two-drug combinations. In conclusion, we identified several highly effective agents with potent anti-tumor activity in chondrosarcoma cells, independent of IDH mutation status. These agents represent promising candidates for chondrosarcoma therapy and warrant further preclinical investigation and potential inclusion in clinical trials. Full article
(This article belongs to the Special Issue Molecular and Translational Research on Bone Tumors, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Drug sensitivity testing workflow. A total of 215 anticancer drugs were tested in chondrosarcoma cell lines JJ012 and HT1080, as well as their respective mutant IDH1 KO derivatives, J14 and H2. Each drug was dissolved in 100% DMSO, starting at a maximum concentration of 10 μM and then diluted across a 20,000-fold concentration range. A total of 1000 cells were seeded per well in 384-well microtiter plates. After 72 h of treatment, cell viability was assessed, and dose-response curves were generated. The DST algorithm was used to calculate the DSS<sub>mod</sub> value for each drug. Drugs with a DSS<sub>mod</sub> value greater than 5 were considered to show significant cancer cell-killing activity.</p>
Full article ">Figure 2
<p>DSS<sub>mod</sub> profiling in chondrosarcoma cell lines. The DSS<sub>mod</sub> profile for each cell line shows compounds with a DSS<sub>mod</sub> value greater than 5, indicating significant cancer cell-killing activity.</p>
Full article ">Figure 3
<p>Validation of drug sensitivity testing results. Docetaxel (2 h), methotrexate (72 h), panobinostat (72 h), idarubicin (2 h), camptothecin (24 h), and pevonedistat (24 h) were evaluated via clonogenic assays to determine their effects on cell survival in chondrosarcoma cells.</p>
Full article ">Figure 4
<p>Docetaxel (2 h), idarubicin (2 h), methotrexate (72 h), camptothecin (24 h), panobinostat (72 h), and pevonedistat (24 h) induced apoptosis in chondrosarcoma cells. Total (early and late stages) apoptosis was statistically analyzed (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Docetaxel (2 h), idarubicin (2 h), methotrexate (72 h), camptothecin (24 h), panobinostat (72 h), and pevonedistat (24 h) induced cell cycle arrest in chondrosarcoma cells. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 6
<p>Two-dimensional synergy map showing the synergistic effects of two-drug combinations in chondrosarcoma cells (ZIP score &gt; 10). Rectangles highlight the most synergistic areas.</p>
Full article ">Figure 7
<p>Drug sensitivity analysis in mutant IDH knockout cells compared to parental cells. (<b>A</b>) The sDSS<sub>mod</sub> profiling for J14 and H2 cells shows drugs with a score greater than +5, indicating favorable effects on mutant IDH1 KO cells. (<b>B</b>) Validation of the top two hit drugs from J14 and H2 profiling using clonogenic assays. Top: The effects of floxuridine (48 h) and dasatinib (24 h) on cell survival were evaluated in J14 and JJ012 cells. Bottom: The effects of vincristine (2 h) and idarubicin (2 h) on cell survival were evaluated in H2 and HT1080 cells.</p>
Full article ">
10 pages, 2976 KiB  
Article
Inferior-to-Superior Dissection for Recurrent Laryngeal Nerve Identification in Redo Thyroid Surgery: Enhanced Safety and Reduced Injuries
by Serdar Gumus, Cemil Yuksel, Huseyin Pulat, Cuneyt Akyuz and Mehmet Onur Gul
J. Clin. Med. 2024, 13(23), 7364; https://doi.org/10.3390/jcm13237364 - 3 Dec 2024
Viewed by 470
Abstract
Background: Hoarseness due to recurrent laryngeal nerve (RLN) injury is the most feared complication of thyroid surgery. Scars and anatomical changes caused by previous surgeries make finding the RLN during redo thyroid surgeries difficult. We aimed to analyze the results of the inferior-to-superior [...] Read more.
Background: Hoarseness due to recurrent laryngeal nerve (RLN) injury is the most feared complication of thyroid surgery. Scars and anatomical changes caused by previous surgeries make finding the RLN during redo thyroid surgeries difficult. We aimed to analyze the results of the inferior-to-superior dissection technique that we applied to find the RLN in redo surgeries. Methods: We analyzed the results of 40 consecutive redo thyroidectomy cases in which the inferior-to-superior nerve dissection technique was used to identify the RLN. We compared this cohort with primary thyroidectomies using a lateral-to-medial approach to determine the reliability of this technique. Results: Most patients were women (80%), and the mean age was 48.1 years. The ASA score was mostly 2. In total, 25% of the patients had a preoperative diagnosis of malignancy. A total of 8 of the patients underwent unilateral surgery and 32 underwent bilateral surgeries. Two patients had previous recurrent laryngeal nerve paralysis (RLNP), but one of them underwent contralateral surgery. Permanent recurrent laryngeal nerve paralysis developed in only 2 of 71 RLNs at risk (2.8%). Complications classified as Clavien-Dindo 3 and above were observed in 12.5% of our patients during the early postoperative period. The transient hypocalcemia rate was 7.5%, and the permanent hypocalcemia rate was 5%. A 2.8% unilateral RLPN rate was detected, but bilateral RLNP was not observed. All of the complications were not observed to be statistically different among those who underwent primary thyroidectomy. Conclusions: The inferior-to-superior nerve dissection approach is a beneficial technique in redo thyroidectomy for preserving RLNP. Surgeons should keep this technique in mind to prevent hoarseness. Full article
(This article belongs to the Special Issue New Insights into Head and Neck Surgery)
Show Figures

Figure 1

Figure 1
<p>Lore’s triangle.</p>
Full article ">Figure 2
<p>Demonstration of the RLN on Lore’s triangle.</p>
Full article ">Figure 3
<p>Inferior-to-superior dissection approach steps. The image shows the right-side dissection of a redo thyroidectomy. The RLN was dissected from caudal to cranial in Lore’s triangle. The white arrow indicates the trachea (T), the yellow arrow indicates the RLN, and the beige arrow indicates the lower parathyroid gland (PTG). CC is the common carotid artery, SM is the strap muscles, and TG is the inferior pole of thyroid gland (<b>a</b>). Retracted strap muscles. (<b>b</b>,<b>c</b>) The lower border of the recurrent thyroid is pulled superiorly and medially with Babcock. (<b>d</b>,<b>e</b>) Lore’s triangle is dissected with a right-angle clamp, and the RLN is dissected from caudal to cranial. (<b>f</b>) The nerve is detected with IONM. (<b>g</b>) The nerve extends from inferior to superior.</p>
Full article ">Figure 4
<p>Identification of parathyroid glands. The yellow arrow indicates the RLN, and the beige arrow indicates the lower parathyroid gland (PTG).</p>
Full article ">
30 pages, 2355 KiB  
Review
The Role of Snake Venom Proteins in Inducing Inflammation Post-Envenomation: An Overview on Mechanistic Insights and Treatment Strategies
by Sudharshan Rao, Nisha Reghu, Bipin Gopalakrishnan Nair and Muralidharan Vanuopadath
Toxins 2024, 16(12), 519; https://doi.org/10.3390/toxins16120519 - 2 Dec 2024
Viewed by 1179
Abstract
The intricate combination of organic and inorganic compounds found in snake venom includes proteins, peptides, lipids, carbohydrates, nucleotides, and metal ions. These components work together to immobilise and consume prey through processes such as paralysis and hypotension. Proteins, both enzymatic and non-enzymatic, form [...] Read more.
The intricate combination of organic and inorganic compounds found in snake venom includes proteins, peptides, lipids, carbohydrates, nucleotides, and metal ions. These components work together to immobilise and consume prey through processes such as paralysis and hypotension. Proteins, both enzymatic and non-enzymatic, form the primary components of the venom. Based on the effects they produce, venom can be classified as neurotoxic, hemotoxic, and cytotoxic. Studies have shown that, after envenomation, proteins in snake venom also contribute significantly to the induction of inflammatory responses which can either have systemic or localized consequences. This review delves into the mechanisms by which snake venom proteins trigger inflammatory responses, focusing on key families such as phospholipase A2, metalloproteinases, serine proteases, C-type lectins, cysteine-rich secretory proteins, and L-amino acid oxidase. In addition, the role of venom proteins in activating various inflammatory pathways, including the complement system, inflammasomes, and sterile inflammation are also summarized. The available therapeutic options are examined, with a focus on antivenom therapy and its side effects. In general, this review offers a comprehensive understanding of the inflammatory mechanisms that are triggered by snake venom proteins and the side effects of antivenom treatment. All these emphasize the need for effective strategies to mitigate these detrimental effects. Full article
(This article belongs to the Special Issue Snake Venom: Toxicology and Associated Countermeasures)
Show Figures

Figure 1

Figure 1
<p>Inflammatory mechanisms induced by snake venom PLA<sub>2</sub>s (green color boxes) isolated from various snake species. TNF-α, tumor necrosis factor-alpha; IL, interleukin; NLRP3, nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3; H<sub>2</sub>O<sub>2</sub> hydrogen peroxide; LTB4 leukotriene B4; NETosis, neutrophil extracellular traps; LDH, lactate dehydrogenase.</p>
Full article ">Figure 2
<p>Inflammatory mechanisms induced by SVMPs (orange color boxes) isolated from various snake species. TNF-α, tumor necrosis factor-alpha; IL, interleukin; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; PGE2, prostaglandin E2; vWF, von Willebrand factor.</p>
Full article ">Figure 3
<p>Inflammatory mechanisms induced by snake venom CTLs (purple color boxes) isolated from various snake species. TNF-α, tumor necrosis factor-alpha; IL, interleukin; ROS, reactive oxygen species; NLRP3, nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3; TLR-4, toll-like receptor-4.</p>
Full article ">Figure 4
<p>Inflammatory mechanisms induced by snake venom CRISPs (squash color boxes) isolated from various snake species. TNF-α, tumor necrosis factor-alpha; IL, interleukin; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1; C3a, complement component 3a; C4a, complement component 4a; C5a, complement component 5a.</p>
Full article ">Figure 5
<p>NLRP3 inflammasome activation by various snake venom proteins and its effector functions. TNF-α, tumor necrosis factor-α; IL, interleukin; NLRP3, nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3; ROS, reactive oxygen species; GSDMD, gasdermin D; BD1, dimethyl ester of bilirubin; ATP, adenosine triphosphate; ASC, apoptosis-associated speck-like protein; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; TLR-4, toll-like receptor-4; TNFR, tumor necrosis factor receptor; IL-1R1, interleukin-1 receptor 1; PAMPs/DAMPs, pathogen/damage-associated molecular patterns. The venom proteins/crude venom responsible for inducing inflammasome activation are highlighted in different colors; green- phospholipase A<sub>2</sub>; dark yellow-snake venom serine protease; purple-C-type lectins, white-L-amino acid oxidase; Orange-three finger toxins.</p>
Full article ">Figure 6
<p>Possible mechanisms of sterile inflammation elicited by snake venom proteins post envenomation. TNF-α, tumor necrosis factor-alpha; IL, interleukin; NLRP3, nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3; ROS, reactive oxygen species; PGE2, prostaglandin E2; LTB4 leukotriene B4; NETs, neutrophil extracellular traps; H<sub>2</sub>O<sub>2</sub> hydrogen peroxide; DAMPs, damage-associated molecular patterns; PGD2, prostaglandin D2.</p>
Full article ">
20 pages, 18117 KiB  
Article
Beyond Poliomyelitis: A 21-Year Study of Non-Polio Enterovirus Genotyping and Its Relevance in Acute Flaccid Paralysis in São Paulo, Brazil
by Rita Cássia Compagnoli Carmona, Fabricio Caldeira Reis, Audrey Cilli, Juliana Monti Maifrino Dias, Bráulio Caetano Machado, Daniele Rita de Morais, Adriana Vieira Jorge, Amanda Meireles Nunes Dias, Cleusa Aparecida de Sousa, Sabrina Bonetti Calou, Gabriel Henriques Ferreira, Lucas Leme, Maria do Carmo Sampaio Tavares Timenetsky and Maria Bernadete de Paula Eduardo
Viruses 2024, 16(12), 1875; https://doi.org/10.3390/v16121875 - 1 Dec 2024
Viewed by 938
Abstract
In the context of the near-global eradication of wild poliovirus, the significance of non-polio enteroviruses (NPEVs) in causing acute flaccid paralysis (AFP) and their impact on public health has gained increased attention. This research, conducted from 2001 to 2021, examined stool samples from [...] Read more.
In the context of the near-global eradication of wild poliovirus, the significance of non-polio enteroviruses (NPEVs) in causing acute flaccid paralysis (AFP) and their impact on public health has gained increased attention. This research, conducted from 2001 to 2021, examined stool samples from 1597 children under 15 years in São Paulo, Brazil, through the AFP/Poliomyelitis Surveillance Program, detecting NPEVs in 6.9% of cases. Among the 100 NPEV-positive strains analyzed, 90 were genotyped through genomic sequencing of the partial VP1 region, revealing a predominance of EV-B species (58.9%), followed by EV-A (27.8%) and EV-C (13.3%). This study identified 31 unique NPEV types, including EV-A71, CVB2, and E11, as the most prevalent, along with the first documented occurrence of CVA19 in Brazil. These findings emphasize the importance of NPEV genotyping in distinguishing AFP from poliomyelitis, enhancing understanding of these viruses’ epidemiology. Moreover, it ensures that AFP cases are correctly classified, contributing to the effective surveillance and eradication efforts for poliomyelitis. Full article
(This article belongs to the Section Human Virology and Viral Diseases)
Show Figures

Figure 1

Figure 1
<p>Cumulative cases (%) of NPEV-positive cases in the AFP/Poliomyelitis Surveillance Program by month during 2001–2021.</p>
Full article ">Figure 2
<p>Distribution of <span class="html-italic">EV-A</span>, <span class="html-italic">EV-B,</span> and <span class="html-italic">EV-C</span> species, from 2001 to 2021. NTEV: not type EV.</p>
Full article ">Figure 3
<p>Multiple-sequence-alignment analysis (a, c, g, and t nucleotide window: 150–175) and maximum clade credibility (MCC) tree from partial sequences (VP1) of <span class="html-italic">EV-A</span> species: EV-A71 (321 bp), CVA2 (304 bp), CVA3 (301 bp), CVA4 (306 bp), CVA5 (300 bp), CVA6 (294 bp), CVA8 (329 bp), CVA10 (332 bp), and CVA16 (335 bp). The genotype was defined as more than 75% nucleotide similarities in the VP1 region. GenBank reference strains are highlighted in blue. Genotypes isolated in this study are highlighted in red. The rate of nucleotide substitution (Bayesian MCMC) is shown by the color gradient in the phylogenetic tree.</p>
Full article ">Figure 4
<p>Multiple-sequence-alignment analysis (a, c, g, and t nucleotide window: 150–175) and maximum clade credibility (MCC) tree from partial sequences (VP1) of <span class="html-italic">EV-B</span> species: CVB2 (331 bp), CVB3 (327 bp), CVB4 (322 bp), CVB5 (33 bp), E1 (334 bp), E3 (319 bp), E6 (332 bp), E7 (334 bp), E9 (309 bp), E11 (33 bp), E13 (334 bp), E14 (317 bp), E16 (317 bp), E18 (311 bp), E25 (334 bp), E30 (318 bp). The genotype was defined as more than 75% nucleotide similarities in the VP1 region. GenBank reference strains are highlighted in blue. Genotypes isolated in this study are highlighted in red. The rate of nucleotide substitution (Bayesian MCMC) is shown by the color gradient in the phylogenetic tree.</p>
Full article ">Figure 5
<p>Multiple-sequence-alignment analysis (a, c, g, and t nucleotide window: 150–175) and maximum clade credibility (MCC) tree from partial sequences (VP1) of <span class="html-italic">EV-C</span> species: EV-C99 (333 bp), CVA11 (363 bp), CVA13 (338 bp), CVA19 (332 bp), and CVA24 (364 bp). The genotype was defined as more than 75% nucleotide similarities in the VP1 region. GenBank reference strains are highlighted in blue. Genotypes isolated in this study are highlighted in red. The rate of nucleotide substitution (Bayesian MCMC) is shown by the color gradient in the phylogenetic tree.</p>
Full article ">
17 pages, 2334 KiB  
Article
Exploring the Neuroprotective Effects of Grape Seed Procyanidins on Amyloid-β-Induced Toxicity in Caenorhabditis elegans
by Susana González-Manzano, Begoña Ayuda-Durán, Roberto Martín-Sanz, Lidia Garzón-García, Celestino Santos-Buelga and Ana María González-Paramás
Foods 2024, 13(23), 3865; https://doi.org/10.3390/foods13233865 - 29 Nov 2024
Viewed by 773
Abstract
Alzheimer’s disease (AD), a major neurodegenerative disorder, is characterized by the progressive accumulation of amyloid-β (Aβ) plaques, leading to cognitive decline. Despite the existing treatments, their limited efficacy highlights the urgent need for novel therapeutic strategies. The present study investigates the neuroprotective effects [...] Read more.
Alzheimer’s disease (AD), a major neurodegenerative disorder, is characterized by the progressive accumulation of amyloid-β (Aβ) plaques, leading to cognitive decline. Despite the existing treatments, their limited efficacy highlights the urgent need for novel therapeutic strategies. The present study investigates the neuroprotective effects of a grape seed polyphenol extract (GSPE) on transgenic Caenorhabditis elegans models specifically expressing human Aβ proteins. The obtained results show that GSPE not only significantly attenuates Aβ-induced paralysis but also extends the lifespan and improves sensory responses in these models, suggesting improved neural function and overall health. Additionally, GSPE treatment reduces proteasomal activity, which could lead to a reduction in the accumulation of misfolded proteins. It also modulates the expression of key genes involved in autophagy and proteostasis, thereby enhancing cellular mechanisms to manage protein aggregation and combat oxidative stress. On the whole, these findings support the potential of grape seed procyanidins (the main components in the extract) to be used as an effective dietary approach to mitigate Alzheimer’s disease pathology through the modulation of critical neuroprotective pathways. Full article
(This article belongs to the Special Issue The Health Benefits of Food-Derived Bioactive Ingredients)
Show Figures

Figure 1

Figure 1
<p>HPLC chromatogram of the prepared GSPE recorded at 280 nm. Peak identities are given in <a href="#foods-13-03865-t002" class="html-table">Table 2</a>.</p>
Full article ">Figure 2
<p>Progression of paralysis rates in the CL4176 strain grown with or without GSPE (100 µg/mL). Data represent the average of three independent experiments (<span class="html-italic">n</span> = 100 worms per group). * Statistically significant differences at <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Kaplan–Meier survival curves of the CL2006 worms at 20 °C in the absence (control) and presence of GSPE (100 µg/mL). The plots were obtained from three independent experiments (n = 100 worms/experiment).</p>
Full article ">Figure 4
<p>Chemotaxis behavior of the CL2355 strain grown in the absence (positive control) and presence of GSPE (100 µg/mL) after thermal induction (25 °C). The error bars represent the standard deviation. * significant at <span class="html-italic">p</span> ≤ 0.05 compared to the negative control; # significant at <span class="html-italic">p</span> ≤ 0.05 compared to the positive control.</p>
Full article ">Figure 5
<p>Proteasomal activity in the transgenic CL2006 worms 120 h after treatment with GSPE (100 µg/mL). The results are expressed as a percentage relative to the average value obtained in non-treated worms (control), designated as 100%. Data are indicated as mean ± SD (n = 8). * significant at <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 6
<p>Relative mRNA expression levels of <span class="html-italic">cpr-5</span>, <span class="html-italic">epg-8</span>, <span class="html-italic">imp-2</span>, <span class="html-italic">rab-7</span>, and <span class="html-italic">vha-5</span> in <span class="html-italic">C. elegans</span> CL4176 grown with (treatment: 100 µg/mL GSPE, red bars) or without GSPE (control, blue bars). Measurements were performed by RT-qPCR using <span class="html-italic">act-1</span> as a reference. Data represent the mean ± SEM from six independent experiments, with statistical significance set at * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
26 pages, 1476 KiB  
Review
From Omics to Multi-Omics: A Review of Advantages and Tradeoffs
by C. Nelson Hayes, Hikaru Nakahara, Atsushi Ono, Masataka Tsuge and Shiro Oka
Genes 2024, 15(12), 1551; https://doi.org/10.3390/genes15121551 - 29 Nov 2024
Viewed by 990
Abstract
Bioinformatics is a rapidly evolving field charged with cataloging, disseminating, and analyzing biological data. Bioinformatics started with genomics, but while genomics focuses more narrowly on the genes comprising a genome, bioinformatics now encompasses a much broader range of omics technologies. Overcoming barriers of [...] Read more.
Bioinformatics is a rapidly evolving field charged with cataloging, disseminating, and analyzing biological data. Bioinformatics started with genomics, but while genomics focuses more narrowly on the genes comprising a genome, bioinformatics now encompasses a much broader range of omics technologies. Overcoming barriers of scale and effort that plagued earlier sequencing methods, bioinformatics adopted an ambitious strategy involving high-throughput and highly automated assays. However, as the list of omics technologies continues to grow, the field of bioinformatics has changed in two fundamental ways. Despite enormous success in expanding our understanding of the biological world, the failure of bulk methods to account for biologically important variability among cells of the same or different type has led to a major shift toward single-cell and spatially resolved omics methods, which attempt to disentangle the conflicting signals contained in heterogeneous samples by examining individual cells or cell clusters. The second major shift has been the attempt to integrate two or more different classes of omics data in a single multimodal analysis to identify patterns that bridge biological layers. For example, unraveling the cause of disease may reveal a metabolite deficiency caused by the failure of an enzyme to be phosphorylated because a gene is not expressed due to aberrant methylation as a result of a rare germline variant. Conclusions: There is a fine line between superficial understanding and analysis paralysis, but like a detective novel, multi-omics increasingly provides the clues we need, if only we are able to see them. Full article
(This article belongs to the Section Molecular Genetics and Genomics)
Show Figures

Figure 1

Figure 1
<p>There are numerous omics methods, but each provides insight into a distinct aspect of the biological state of a sample. Genomics and epigenomics focus on the sequence and accessibility of the genetic material, whereas transcriptomics, proteomics, metabolomics, and glycoinformatics examine the expression levels, post-translational modifications, and biochemical activity of proteins and other biomolecules under different conditions.</p>
Full article ">Figure 2
<p>Multi-omics concepts. Each distinct omics method provides information about a different but incomplete aspect of the internal state of the cell. Joint analysis of two or more omics methods provides more comprehensive insight into key factors that can be used for classification or prediction and or serve as potential biomarkers or drug targets. Created in part using <a href="http://BioRender.com" target="_blank">BioRender.com</a> (accessed on 25 November 2024).</p>
Full article ">
17 pages, 583 KiB  
Review
Neurogenic Aging After Spinal Cord Injury: Highlighting the Unique Characteristics of Aging After Spinal Cord Injury
by Brittany L. Tretter, David R. Dolbow, Vincent Ooi, Gary J. Farkas, Joshua M. Miller, Jakob N. Deitrich and Ashraf S. Gorgey
J. Clin. Med. 2024, 13(23), 7197; https://doi.org/10.3390/jcm13237197 - 27 Nov 2024
Viewed by 556
Abstract
Emanating from several decades of study into the effects of the aging process after spinal cord injury (SCI), “accelerated aging” has become a common expression as the SCI accelerates the onset of age-related pathologies. However, the aging process follows a distinct trajectory, characterized [...] Read more.
Emanating from several decades of study into the effects of the aging process after spinal cord injury (SCI), “accelerated aging” has become a common expression as the SCI accelerates the onset of age-related pathologies. However, the aging process follows a distinct trajectory, characterized by unique patterns of decline that differ from those observed in the general population without SCI. Aging brings significant changes to muscles, bones, and hormones, impacting overall physical function. Muscle mass and strength begin to decrease with a reduction in muscle fibers and impaired repair mechanisms. Bones become susceptible to fractures as bone density decreases. Hormonal changes combined with decreased physical activity accelerate the reduction of muscle mass and increase in body fat. Muscle atrophy and skeletal muscle fiber type transformation occur rapidly and in a unique pattern after SCI. Bone loss develops more rapidly and results in an increased risk of fractures in body regions unique to individuals with SCI. Other factors, such as excessive adiposity, decreased testosterone and human growth hormone, and increased systemic inflammation, contribute to a higher risk of neuropathically driven obesity, dyslipidemia, glucose intolerance, insulin resistance, and increasing cardiovascular disease risk. Cardiorespiratory changes after SCI result in lower exercise heart rates, decreased oxygenation, and mitochondrial dysfunction. While it is important to acknowledge the accelerated aging processes after SCI, it is essential to recognize the distinct differences in the aging process between individuals without physical disabilities and those with SCI. These differences, influenced by neuropathology, indicate that it may be more accurate to describe the aging process in individuals with chronic SCI as neurogenic accelerated aging (NAA). Research should continue to address conditions associated with NAA and how to ameliorate the accelerated rate of premature age-related conditions. This review focuses on the NAA processes and the differences between them and the aging process in those without SCI. Recommendations are provided to help slow the development of premature aging conditions. Full article
(This article belongs to the Section Clinical Neurology)
Show Figures

Figure 1

Figure 1
<p>Skeletal Muscles Changes after SCI.</p>
Full article ">
18 pages, 4870 KiB  
Article
The Role of PD-1/PD-L1 and IL-7 in Lymphocyte Dynamics and Sepsis Progression: A Biomarker Study in Critically Ill Patients
by Oana Coman, Bianca-Liana Grigorescu, Adina Huțanu, Anca Bacârea, Anca Meda Văsieșiu, Raluca Ștefania Fodor, Marius Petrișor and Leonard Azamfirei
Int. J. Mol. Sci. 2024, 25(23), 12612; https://doi.org/10.3390/ijms252312612 - 24 Nov 2024
Viewed by 689
Abstract
Sepsis pathophysiology involves a dysregulated immune response to infection, excessive inflammation, and immune paralysis. This study explores the relationships between cell death biomarkers (serum-soluble levels of programmed cell death protein 1 (PD-1), programmed death ligand 1 (PD-L1), and interleukin-7 (IL-7)) and the percentages [...] Read more.
Sepsis pathophysiology involves a dysregulated immune response to infection, excessive inflammation, and immune paralysis. This study explores the relationships between cell death biomarkers (serum-soluble levels of programmed cell death protein 1 (PD-1), programmed death ligand 1 (PD-L1), and interleukin-7 (IL-7)) and the percentages of various lymphocyte subsets in relation to the severity and progression of sepsis. This prospective, observational study included 87 critically ill patients. We monitored parameters on days 1 (sepsis was diagnosed according to the Sepsis-3 Consensus) and 5. We established an IL-7 cutoff value of 1.94 pg/mL by comparing levels between a healthy control group and patients with sepsis (p < 0.0001). Lymphopenia was observed in all patients, with negative correlations between helper T lymphocytes and cytotoxic and B lymphocytes, and positive correlations involving cytotoxic lymphocytes across all groups. We found correlations between PD-1/PD-L1 and lymphocyte subsets. IL-7 showed a statistical correlation with PD-1 in non-survivors. Assessing lymphocyte levels shows potential as a biomarker for evaluating the progression of sepsis. Monitoring IL-7 levels could help assess survival, as low levels are associated with higher mortality risk. Monitoring IL-7 levels could help assess survival, as low levels are associated with higher mortality risk. Elevated PD-1/PD-L1 expression impairs costimulatory signalling, reducing T cell responses and lymphopenia, which increases the risk of nosocomial infections. Full article
(This article belongs to the Special Issue Cell Apoptosis, 3rd Edition)
Show Figures

Figure 1

Figure 1
<p>The standard ROC curve analysis of all patients and the control group.</p>
Full article ">Figure 2
<p>PD-L1 variation for septic shock patients between day 1 and day 5 (Wilcoxon test). D1: day 1, D5: day 5.</p>
Full article ">Figure 3
<p>Statistically significant correlation between lymphocyte subtypes Th CD4+, Tc CD8+, and NKT on day 1 (<b>A</b>–<b>D</b>) and day 5 (<b>E</b>–<b>G</b>) in the sepsis group; <sup>a</sup> Spearman test, <sup>b</sup> Pearson test.</p>
Full article ">Figure 4
<p>Statistically significant correlation between lymphocyte subtypes Th CD4+, Tc CD8+, and NKT on day 1 (<b>A</b>,<b>B</b>) and day 5 (<b>C</b>,<b>D</b>) in the septic shock group; <sup>a</sup> Spearman test, <sup>b</sup> Pearson test.</p>
Full article ">Figure 5
<p>NKT lymphocyte variation for the survivor lot of patients between day 1 and day 5 (<b>A</b>). IL-7 variation for the non-survivor lot of patients between day 1 and day 5 (<b>B</b>). D1: day 1, D5: day 5.</p>
Full article ">
15 pages, 2721 KiB  
Article
Does Muscle Pain Induce Alterations in the Pelvic Floor Motor Unit Activity Properties in Interstitial Cystitis/Bladder Pain Syndrome? A High-Density sEMG-Based Study
by Monica Albaladejo-Belmonte, Michael Houston, Nicholas Dias, Theresa Spitznagle, Henry Lai, Yingchun Zhang and Javier Garcia-Casado
Sensors 2024, 24(23), 7417; https://doi.org/10.3390/s24237417 - 21 Nov 2024
Viewed by 481
Abstract
Several studies have shown interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic condition that poses challenges in both diagnosis and treatment, is associated with painful pelvic floor muscles (PFM) and altered neural drive to these muscles. However, its pathophysiology could also involve other alterations [...] Read more.
Several studies have shown interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic condition that poses challenges in both diagnosis and treatment, is associated with painful pelvic floor muscles (PFM) and altered neural drive to these muscles. However, its pathophysiology could also involve other alterations in the electrical activity of PFM motor units (MUs). Studying these alterations could provide novel insights into IC/BPS and help its clinical management. This study aimed to characterize PFM activity at the MU level in women with IC/BPS and pelvic floor myalgia using high-density surface electromyography (HD-sEMG). Signals were recorded from 15 patients and 15 healthy controls and decomposed into MU action potential (MUAP) spike trains. MUAP amplitude, firing rate, and magnitude-squared coherence between spike trains were compared across groups. Results showed that MUAPs had significantly lower amplitudes during contractions on the patients’ left PFM, and delta-band coherence was significantly higher at rest on their right PFM compared to controls. These findings suggest altered PFM tissue and neuromuscular control in women with IC/BPS and pelvic floor myalgia. Our results demonstrate that HD-sEMG can provide novel insights into IC/BPS-related PFM dysfunction and biomarkers that help identify subgroups of IC/BPS patients, which may aid their diagnosis and treatment. Full article
(This article belongs to the Special Issue Advances in Electrophysiology Monitoring and Analysis)
Show Figures

Figure 1

Figure 1
<p>Dimensions of the grid of electrodes (numbered from 1 to 64) and intravaginal probe used for HD-sEMG detection.</p>
Full article ">Figure 2
<p>Steps performed to characterize MU properties from decomposed HD-sEMG signals and to compare them between IC/BPS patients and healthy controls. Red crosses on the HD-sEMG grid (3) show the MUs located on the right and left PFM.</p>
Full article ">Figure 3
<p>Motor unit action potential amplitude (<span class="html-italic">Amp</span>) on the PFM left and right sides in patients (dark boxes) and healthy controls (light boxes) during pelvic floor muscles’ maximum voluntary contractions (MVC; <b>a</b>,<b>b</b>) and at rest (<b>c</b>,<b>d</b>). (*): statistically significant difference.</p>
Full article ">Figure 4
<p>Motor unit action potential firing rate (<span class="html-italic">FR</span>) on the PFM left and right sides in patients (dark boxes) and healthy controls (light boxes) during pelvic floor muscles maximum voluntary contractions (MVC; <b>a</b>,<b>b</b>) and at rest (<b>c</b>,<b>d</b>).</p>
Full article ">Figure 5
<p>Magnitude-squared coherence (<span class="html-italic">mscoh</span>) on the left and right PFM in patients (light boxes) and healthy controls (dark boxes) during pelvic floor muscles maximum voluntary contractions (MVC; <b>a</b>,<b>b</b>) and at rest (<b>c</b>,<b>d</b>). (*): statistically significant difference.</p>
Full article ">
Back to TopTop